40 reports

Medicine; ##(##): ##-##.

  • Hepatitis Treatment
  • AbbVie Inc.
  • Gilead Sciences, Inc.
  • Janssen Biotech, Inc.
  • Merck & Co., Inc.

Hepatitis C ##. ##. ## Opportunities and Threats in the Hepatitis C Therapies Market, 2016-2027 ##. ##. ##. ## Hepatitis Screening and Diagnosis ##. ##. ##. ## Raising Awareness and Overcoming Social Stigma ##. ##. ##. ## Personalised Therapy ##. ##. ##. ## HIV Co-Infection ##. ##. ##. ## Asia ##. ## STEP Analysis of the Wo

  • Antiviral
  • Hepatitis Treatment
  • Therapy
  • Forecast
  • Market Size

EMBO Molecular Medicine; ##(##): ##-## Lawitz E, et al. (2013).

  • Hepatitis Treatment
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • Roche Group

Global Market Study on Hepatitis C Treatment: Online Pharmacies Distribution Channel Segment Expected to Register the Fastest CAGR of ##. ##% During 2016 - 2024 ##.

  • Hepatitis Treatment
  • Therapy
  • World
  • Market Size
  • PRODUCT PROFILE - PREZCOBIX

Presentation at the ##th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy, Washington, DC, US.

  • Hepatitis Treatment
  • Asia
  • Japan
  • Gilead Sciences, Inc.
  • ViiV Healthcare Ltd.
  • Market drivers

IFN has been considered a cornerstone for hepatitis treatment since its launch.

  • Hepatitis Treatment
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • LICENSING AGREEMENTS

The agreement also permit the manufacture of sofosbuvir or ledipasvir in combination with other chronic hepatitis C medicines.

  • Hepatitis Treatment
  • HIV AIDS
  • Pharmaceutical
  • India
  • Mylan Inc.

Food and Drug Administration (FDA) and European Medicines Agency (EMA) for hepatitis delta virus infection.

  • Hepatitis
  • Hepatitis Treatment
  • United States
  • Product Initiative
  • REPLICor Inc.
  • GILEAD SCIENCES, INC.: SWOT ANALYSIS
  • GILEAD SCIENCES, INC.: COMPANY HISTORY

Gilead helped revolutionize the treatment of viral hepatitis, which affects approximately half a billion people worldwide, by providing medicines that cure chronic hepatitis C infection and manage chronic hepatitis B infection more effectively.

  • Hepatitis Treatment
  • Pharmaceutical
  • United States
  • Company
  • Gilead Sciences, Inc.

He completed his internal medicine residency at Boston' s Beth Israel Hospital and is board certified in Internal Medicine.

  • Hepatitis Treatment
  • United States
  • Corporate Finance
  • Demand
  • Gilead Sciences, Inc.
  • GILEAD SCIENCES ENTERS INTO LICENSING AGREEMENT WITH HETERO LABS
  • GILEAD SCIENCES EXPANDS LICENSING AGREEMENT WITH STRIDES SHASUN

The agreement also permit the manufacture of sofosbuvir or ledipasvir in combination with other chronic hepatitis C medicines.

  • Hepatitis Treatment
  • HIV AIDS
  • Pharmaceutical
  • United States
  • Gilead Sciences, Inc.

The company focuses at developing life-saving medicines to patients with rare diseases.

  • Hepatitis Treatment
  • Pharmaceutical
  • United States
  • Company Operations
  • Achillion Pharmaceuticals, Inc.

This agreement enables Mylan, MPP and BMS for access to the hepatitis C medicine daclatasvir (DCV).

  • Hepatitis Treatment
  • United States
  • Company
  • Company Financials
  • Mylan Inc.

Galpagos is a clinicalstage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes of action and working with it in collaboration will help Gilead to achieve faster results and better efficiency.

  • Hepatitis Treatment
  • Europe
  • World
  • Forecast
  • Gilead Sciences, Inc.

Tarek Hassanein, M. D., FACP, FACG, AGAF, FAASLD, Professor of Medicine, UCSD School of Medicine, Director of Outreach Services, UCSD Center for Transplantation, Director, Southern California GI & Liver Centers, Medical Director, Southern California Research Center, USA; Mr.

  • Hepatitis Treatment
  • Therapy
  • United States
  • Company
  • ContraVir Pharmaceuticals, Inc.

Hepatitis D clinical trial report consists of ## trials.

  • Clinical Trial
  • Hepatitis Treatment
  • Pharmaceutical
  • World
  • Product Initiative
  • 3. Hepatitis C - Approved Drugs Sales & Forecast
  • The six main reasons for the high price-tags on promising new HCV drugs

This agreement allows Natco to expand access to these chronic hepatitis C medicines in ## developing countries.

  • Hepatitis Treatment
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.

Kyle McCommis from the Washington University School of Medicine, St.

  • Clinical Trial
  • Digestive System Disorder
  • Hepatitis Treatment
  • World
  • Product Initiative

Hepatitis C

4546 5000 3864

Annals of Internal Medicine, ##(##), ##-## < PMID> ##< / PMID>.

  • Hepatitis Treatment
  • Asia
  • Europe
  • Japan
  • World

It provides medicines, vaccines and consumer healthcare products.

  • Hepatitis
  • Hepatitis Treatment
  • Pathology
  • Pharmaceutical
  • Merck & Co., Inc.

Cipla, Emcure, Hetero and Natco signed nonexclusive, royalty free agreements with Bristol-Myers Squibb and The Medicines Patent Pool (MPP), to manufacture and sell a hepatitis C drug, Daclatasvir in ## low- and middle-income countries.

  • Hepatitis Treatment
  • Pharmaceutical
  • India
  • Company
  • Cipla Ltd

These medicines are used to treat people with hepatitis B and C, HIV, influenza, and pulmonary diseases.

  • Hepatitis Treatment
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Gilead Sciences Enters into Licensing Agreement with Hetero Labs

The agreement also permit the manufacture of sofosbuvir or ledipasvir in combination with other chronic hepatitis C medicines.

  • Hepatitis Treatment
  • Europe
  • India
  • United States
  • Hetero Drugs Limited

Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver Transplantation (LT) GDCT## NCT##, Gastrointestinal Hepatitis B, Liver Cirrhosis Completed Phase IV Observational hepatitis B immune globulin (human) Seoul St.

  • Antiviral
  • Clinical Trial
  • Digestive System Disorder
  • Hepatitis Treatment
  • World
  • Clinical Trial profile. 2077 Trial Title
  • Clinical Trial
  • Drug Discovery And Development
  • Hepatitis Treatment
  • Pharmaceutical
  • World

In November 2016, the Ministry of Health announced that it had renegotiated the price of Hepatitis C drugs daclatasvir, sofosbuvir, simeprevir, and HIV medicine dolutegravir, securing a ##% discount (calculated in R$, per pack), understood to be applied at the level of the PF.

  • Hepatitis Treatment
  • Therapy
  • Brazil
  • Demand
  • GlaxoSmithKline plc

Korean Journal of Internal Medicine; ##(##): ##-## Lai HW, et al. (2009).

  • Hepatitis Treatment
  • Therapy
  • World
  • Gilead Sciences, Inc.
  • Tekmira Pharmaceuticals Corporation

Since this time, more than ##, ## people have received a PBS-subsidized medicine to treat chronic hepatitis C.

  • Antiviral
  • Hepatitis
  • Hepatitis Treatment
  • Research And Development
  • Bristol-Myers Squibb Company

Hepabig injection_IIT Gastrointestinal Hepatitis B, Liver Cirrhosis Completed Phase IV Observational hepatitis B immune globulin (human) Seoul St.

  • Clinical Trial
  • Digestive System Disorder
  • Hepatitis Treatment
  • Pharmaceutical
  • World

Hepatitis A Phase II Clinical Trial of Hydronidone Capsules(F##) in Patients with Liver Fibrosis Induced by HBV Chronic Hepatitis GDCT## GDC##, NCT##; GNI-F##-## Gastrointestinal Hepatitis B, Liver Fibrosis Ongoing, recruiting Phase II Interventional

  • Clinical Trial
  • Drug Discovery And Development
  • Hepatitis Treatment
  • World
  • Product Initiative